Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis

Published:2016-04 Issue: Volume:94 Page:46-53
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chen Li-Yang^ORCID,Molina-Vila Miguel A.,Ruan Sheng-Yuan,Su Kang-Yi^ORCID,Liao Wei-Yu,Yu Kai-Lun,Ho Chao-Chi,Shih Jin-Yuan,Yu Chong-Jen,Yang James Chih-Hsin,Rosell Rafael,Yang Pan-Chyr

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

2. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers;Yu;Clin. Cancer Res.,2013

3. Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer;Inukai;Cancer Res.,2006

4. Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing;Yu;Ann. Oncol.,2014

5. The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis;Ding;Onco Targets Ther.,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary versus acquired epidermal growth factor receptor Thr790Met mutant non-small cell lung cancer: clinical features and prognoses;Clinical and Translational Oncology;2024-01-08

2. Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India;International Journal of Molecular and Immuno Oncology;2023-11-25

3. Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKI;Cancer Biomarkers;2023-11-23

4. Frequency of EGFR mutations in lung adenocarcinoma patients – A study from tertiary cancer center of South India;Journal of Cancer Research and Therapeutics;2023-09-21

5. The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies;Pharmaceutics;2023-05-27